睡眠医学教育对医学生睡眠质量的影响:前瞻性自身前后对照研究方案

注册号:

Registration number:

ChiCTR2200063664 

最近更新日期:

Date of Last Refreshed on:

2022-09-14 17:27:23 

注册时间:

Date of Registration:

2022-09-14 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

睡眠医学教育对医学生睡眠质量的影响:前瞻性自身前后对照研究方案

Public title:

The effect of sleep medicine education on the sleep quality of medical students: a prospective self-control study protocol

注册题目简写:

English Acronym:

研究课题的正式科学名称:

睡眠医学教育对医学生睡眠质量的影响:前瞻性自身前后对照研究方案

Scientific title:

The effect of sleep medicine education on the sleep quality of medical students: a prospective self-control study protocol

研究课题代号(代码):

Study subject ID:

2022年4月10日第一版

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

程金湘 

研究负责人:

程金湘 

Applicant:

cheng jinxiang 

Study leader:

cheng jinxiang 

申请注册联系人电话:

Applicant telephone:

+86 13720750898

研究负责人电话:

Study leader's
telephone:

+86 13720750898

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

chengjinxiang423@foxmail.com

研究负责人电子邮件:

Study leader's E-mail:

chengjinxiang423@foxmail.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

陕西省西安市灞桥区新寺路569号

研究负责人通讯地址:

陕西省西安市灞桥区新寺路569号

Applicant address:

569 Xinsi Road, Baqiao District, Xi'an, Shaanxi, China

Study leader's address:

569 Xinsi Road, Baqiao District, Xi'an, Shaanxi, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

唐都医院

Applicant's institution:

Tangdu Hospital

研究负责人所在单位:

唐都医院

Affiliation of the Leader:

Tangdu Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

202206-16

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

第四军医大学唐都医院医学伦理委员会

Name of the ethic committee:

Ethics Committee of Institution for National Drug Clinical Trial, Tangdu Hospital, Fourth Military Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2022-06-23 00:00:00

伦理委员会联系人:

李师草

Contact Name of the ethic committee:

Li shicao

伦理委员会联系地址:

陕西省西安市灞桥区新寺路1号第四军医大学唐都医院临床教学楼304室

Contact Address of the ethic committee:

Room 304, Clinical Teaching Building, Tangdu Hospital, 1 Xinsi Road, Baqiao District, Xi'an, Shaanxi, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

029-84717761

伦理委员会联系人邮箱:

Contact email of the ethic committee:

tangduec@126.com

研究实施负责(组长)单位:

唐都医院

Primary sponsor:

Tangdu Hospital

研究实施负责(组长)单位地址:

陕西省西安市灞桥区新寺路569号

Primary sponsor's address:

569 Xinsi Road, Baqiao District, Xi'an, Shaanxi, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

陕西

市(区县):

西安

Country:

China

Province:

Shaanxi

City:

Xi'an

单位(医院):

唐都医院

具体地址:

陕西省西安市灞桥区新寺路569号

Institution
hospital:

Tangdu Hospital

Address:

569 Xinsi Road, Baqiao District, Xi'an, Shaanxi, China

经费或物资来源:

Source(s) of funding:

none

研究疾病:

睡眠障碍  

Target disease:

sleep disorder

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

历史对照研究 

Study design:

Historical control 

研究目的:

明确睡眠医学教育是否有利于改善睡眠,减少不良睡眠对日间功能的影响  

Objectives of Study:

To determine whether sleep medicine education is beneficial for improving sleep and reducing the impact of poor sleep on daytime functioning

药物成份或治疗方案详述:

睡眠医学教育共20学时,课程设置包括睡眠医学进展、睡眠检查、失眠、日间思睡、睡眠呼吸暂停、异态睡眠等。每周2学时,考虑到可能的特殊情况,不能实现每周连续进行,约需要12-14周完成授课。在《睡眠医学》选修课第一节课开始评估接受睡眠医学教育前学员的睡眠质量及其影响因素,《睡眠医学》选修课最后一节课再次进行评估。所有量表均为自评量表,通过问卷星进行学员自评。 

Description for medicine or protocol of treatment in detail:

Sleep medicine education totals 20 hours, and the curriculum includes progress in sleep medicine, sleep examination, insomnia, daytime sleep, sleep apnea, and abnormal sleep. 2 hours per week, taking into account possible special circumstances, can not achieve weekly continuous, it takes about 12-14 weeks to complete the course. The quality of sleep and its influencing factors before receiving sleep medicine education begins in the first class of the "Sleep Medicine" elective course, and the last class of the "Sleep Medicine" elective class is evaluated again. All scales are self-assessment scales, and students are self-assessed by questionnaire stars. 

纳入标准:

Inclusion criteria

排除标准:

不同意参与研究,未能完成睡眠医学选修课90%的课程,未能参加失眠课程的学习。

Exclusion criteria:

Did not agree to participate in the study, failed to complete 90% of the courses of the sleep medicine elective, and failed to attend the insomnia course.

研究实施时间:

Study execute time:

From 2022-09-12 00:00:00 To 2023-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-09-15 00:00:00 To 2023-12-31 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

126

Group:

Experimental group

Sample size:

干预措施:

睡眠医学教育

干预措施代码:

Intervention:

Sleep Medicine Education

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

陕西 

市(区县):

西安 

Country:

China

Province:

Shanxi

City:

Xi'an

单位(医院):

唐都医院 

单位级别:

三甲 

Institution
hospital:

Tangdu Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

匹兹堡睡眠质量指数分数

指标类型:

主要指标

Outcome:

Pittsburgh Sleep Quality Index Score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

失眠严重程度指数分数

指标类型:

次要指标

Outcome:

Insomnia Severity Index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

艾普沃斯嗜睡量表分数

指标类型:

次要指标

Outcome:

Epworth Sleepiness Scale Score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

焦虑自评量表分数

指标类型:

次要指标

Outcome:

Anxiety self-rating scale score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

抑郁自评量表分数

指标类型:

次要指标

Outcome:

Depression self-rating scale score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

睡眠习惯量表

指标类型:

次要指标

Outcome:

Sleep Habits Scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

睡眠信念量表

指标类型:

次要指标

Outcome:

Sleep Belief Scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

清晨夜晚型量表

指标类型:

次要指标

Outcome:

MEQ

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Flinder疲劳量表

指标类型:

次要指标

Outcome:

Flinder fatigue scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

非随机试验

Randomization Procedure (please state who generates the random number sequence and by what method):

nonrandomized trial

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验完成后6个月内在临床试验管理平台公开原始数据。http://www.medresman.org.cn。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Publish the original data in the ResMan within 6 months after the completion of the trial. http://www.medresman.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

我们设计了纸质CRF表,按照纸质的CRF建设好EDC系统,研究者负责采集每位受试者每次随访的信息至EDC系统中,数据管理人 员进行数据管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

We designed the paper CRF and built the EDC system according to the paper CRF,The investigator were responsible for collecting information from each of the subjects every follow-up to the EDC system and data management personnel conduct data management.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2022-09-14 17:27:13